Cover Image
市場調查報告書

全球生技藥品市場

Biologics Global Market Report 2018

出版商 The Business Research Company 商品編碼 603063
出版日期 內容資訊 英文 221 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球生技藥品市場 Biologics Global Market Report 2018
出版日期: 2018年03月14日 內容資訊: 英文 221 Pages
簡介

本報告提供全球生技藥品市場相關調查分析,提供市場特徵,市場規模·成長率,市場區隔,各地區·各國明細,競爭情形,趨勢與策略等系統性資訊。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長率 (實際成果)
  • 市場成長率 (預測)

第3章 趨勢與策略

第4章 大環境分析

  • 政治
  • 經濟
  • 社會
  • 技術性
  • 法律
  • 環境的

第5章 客戶資訊

第6章 各地區·各國分析

  • 各地區
  • 實際成果與預測:各地區
  • 成長率與市場佔有率比較:各地區
  • 各國
  • 實際成果與預測:各國
  • 成長率與市場佔有率比較:各國

第7章 市場區隔:各類型

第8章 市場區隔:各市場區隔

第9章 宏觀經濟要素的比較

  • 市場規模,佔GDP比率:全球
  • 每人平均支出:全球

第10章 宏觀經濟要素的比較:各國

  • 市場規模,佔GDP比率:各國
  • 每人平均支出:各國

第11章 指標的比較

第12章 亞太地區

第13章 西歐

第14章 東歐

第15章 北美

第16章 南美

第17章 中東

第18章 非洲

第19章 競爭情形

  • 企業簡介
  • Amgen
  • AbbVie Inc
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Pfizer Inc

第20章 主要M&A

第21章 市場背景:醫療市場

第22章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, vaccines, and monoclonal antibodies. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

"Biologicals are here to stay, that's what I feel because if you have diseases like cancer infectious diseases, which require these kind of a treatment, then the biologicals are the only way, so, they are required."

Area Business Manager, Johnson & Johnson Ltd.

North America was the largest geographic region in the Global Biologics market in 2017, accounting for $87.3 billion of the market. Western Europe was the second largest geographic market, accounting for $51 billion of the market. Asia Pacific was the third largest geographic market, accounting for $35.6 billion of the market. Eastern Europe accounted for $14 billion, while Middle East accounted for $13.1 billion of the Global Biologics market.

Demand For Biologics In The Treatment Of Complex Diseases

Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, Crohn's disease that have limited treatment options. There has been a significant advance in the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan). Key biologics used to treat psoriasis include Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab ( Cosentyx). Cimzia (certolizumab pegol), Humira (adalimumab), and Remicade (infliximab), Tysabri (natalizumab) are biologics that are used to treat Crohn's disease.

Biologics Global Market Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The biologics market section of the report gives context. It compares the biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Biologics Market Indicators Comparison.

Scope

Markets Covered: Healthcare Services, Pharmaceutical Drugs, Medical Equipment, And Biologics

Companies Mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squib, Pfizer, Eli Lilly and Company, F. Hoffmann-La Roche, Merck & Co., GlaxoSmithKline, Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Biologics Market Indicators Comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Executive Summary 17

Biologics Market Characteristics 18

Market Overview 18

Market Segmentation 20

Market Value Chain 22

Biologics Market Size And Growth 24

Biologics Historic Market Growth 24

Drivers Of The Market 25

Restraints On The Market 26

Biologics Market Forecast Growth 27

Drivers Of The Market 28

Increase In Healthcare Access 28

Restraints On The Market 29

PESTLE Analysis 30

Political 31

Economic 31

Social 31

Technological 32

Legal 32

Environmental 32

Biologics Market Segmentation 33

Global Biologics Market, 2017, Split By Segments, $ Billion 33

Monoclonal Antibodies (mAbs) 34

Therapeutic Proteins 34

Vaccines 34

Global Biologics Market, Historic and Forecast Growth Rates, Split By Segments, 2013-2021 35

Global Biologics Market Trends And Strategies 36

Demand For Biologics In The Treatment Of Complex Diseases 36

Development And Increasing Demand For Next Generation Biologics 36

Revised FDA Regulations To Facilitate Biologics Drug Development 37

Higher Profit Margins For Biologics 37

Higher Investments 37

Global Biologics Market Compared With Similar Markets, 2017 38

Healthcare Market Segmentation, By Region, 2017 38

Healthcare Market Segmentation, By Country, 2017 39

Global Biologics Market Segment Details 41

Monoclonal Antibodies (mAbs) 41

Monoclonal Antibodies Market Characteristics 41

Global Monoclonal Antibodies Market, 2017, By Source 41

Global Monoclonal Antibodies Market, 2017, By Therapeutic Area 43

Monoclonal Antibodies Market Trends And Strategies 45

Therapeutic Proteins 46

Therapeutic Proteins Market Characteristics 46

Global Therapeutic Proteins Market, 2017, By Type 46

Global Therapeutic Proteins Market, 2017, By Therapeutic Area 47

Therapeutic Proteins Market Trends And Strategies 49

Vaccines 50

Vaccines Market Characteristics 50

Global Vaccines Market, 2017, By End User 50

Global Vaccines Market, 2017, By Therapeutic Area 51

Vaccines Market Trends And Strategies 53

Biologics Market Geography Regional and Country Analysis 54

Biologics Market, 2017, By Region 54

Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021 56

Biologics Market, Split By Country, 2017 58

Biologics Market, Historic And Forecast Growth Rates, Split By Country, 2013-2021 60

Global Biologics Market Comparison With Macro Economic Factors 62

Biologics Market Size, Percentage Of GDP, Global 62

Per Capita Average Biologics Expenditure, Global 63

Biologics Market Comparison With Macro Economic Factors Across Countries 64

Biologics Market Size, Percentage of GDP, By Country 64

Per Capita Average Biologics Expenditure, By Country 65

Biologics Market Comparison With Industry Metrics 66

Biologics & Biosimilars Sales Proportion By Country (Value), 2017, By Country 66

Global Biologics Under Development, 2017 68

New Biologics Approvals, 2017 69

Number Of General Practitioners 2016, By Country 70

Average Revenue Per General Practitioner 2016, By Country 71

Biologics Market Regional And Country Analysis 72

Asia-Pacific Biologics Market 72

Asia-Pacific Biologics Market Overview 72

Region Information 72

General Information 72

Government Initiatives 72

Regulations 73

Regulatory Bodies 73

Investments 73

Associations 74

Competitive Landscape 74

Asia Pacific Biologics Market 74

Asia-Pacific Biologics Historic Market, 2013-2017 74

Asia-Pacific Biologics Forecast Market, 2017-2021 75

Asia-Pacific Biologics Market, 2017, By Segment 76

Asia-Pacific Biologics Market: Country Analysis 78

China Biologics Market Overview 78

Country Information 78

General Information 78

Government Initiatives 78

Regulations 78

Regulatory Bodies 78

Investments 78

Associations 79

Competitive Landscape 79

China Biologics Market 79

China Biologics Historic Market, 2013-2017 80

China Biologics Forecast Market, 2017-2021 81

China Biologics Market, 2017, By Segment 82

India Biologics Market Overview 83

Country Information 83

General Information 83

Government Initiatives 83

Regulations 83

Regulatory Bodies 84

Investments 84

Associations 84

Competitive Landscape 84

India Biologics Market 85

India Biologics Historic Market, 2013-2017 85

India Biologics Forecast Market, 2017-2021 86

India Biologics Market, 2017, By Segment 87

Japan Biologics Market Overview 88

Country Information 88

General Information 88

Government Initiatives 88

Regulations 88

Regulatory Bodies 88

Investments 88

Associations 89

Competitive Landscape 89

Japan Biologics Market 89

Japan Biologics Historic Market, 2013-2017 89

Japan Biologics Forecast Market, 2017-2021 90

Japan Biologics Market, 2017, By Segment 91

Australia Biologics Market Overview 93

Country Information 93

General Information 93

Government Initiatives 93

Regulations 93

Australia Biologics Market 93

Australia Biologics Historic Market, 2013-2017 94

Australia Biologics Forecast Market, 2017-2021 95

Australia Biologics Market, 2017, By Segment 96

Western Europe Biologics Market 97

Western Europe Biologics Market Overview 97

Region Information 97

General Information 97

Government Initiatives 97

Regulations 97

Regulatory Bodies 98

Investments 98

Associations 99

Competitive Landscape 99

Western Europe Biologics Market 100

Western Europe Biologics Historic Market, 2013-2017 100

Western Europe Biologics Forecast Market, 2017-2021 101

Western Europe Biologics Market, 2017, By Segment 103

Western Europe Biologics Market: Country Analysis 104

UK Biologics Market Overview 104

Country Information 104

General Information 104

Government Initiatives 104

Regulations 104

Regulatory Bodies 104

Investments 104

Associations 105

Competitive Landscape 105

UK Biologics Market 106

UK Biologics Historic Market, 2013-2017 106

UK Biologics Forecast Market, 2017-2021 107

UK Biologics Market, 2017, By Segment 108

Germany Biologics Market Overview 109

Country Information 109

General Information 109

Government Initiatives 109

Regulations 109

Regulatory Bodies 109

Investments 109

Associations 110

Competitive Landscape 110

Germany Biologics Market 111

Germany Biologics Historic Market, 2013-2017 111

Germany Biologics Forecast Market, 2017-2021 112

Germany Biologics Market, 2017, By Segment 113

France Biologics Market Overview 114

Country Information 114

General Information 114

Government Initiatives 114

Regulations 114

Regulatory Bodies 114

Investments 114

Associations 115

Competitive Landscape 115

France Biologics Market 116

France Biologics Historic Market, 2013-2017 116

France Biologics Forecast Market, 2017-2021 117

France Biologics Market, 2017, By Segment 118

Italy Biologics Market Overview 119

Country Information 119

General Information 119

Regulations 119

Regulatory Bodies 119

Investments 119

Competitive Landscape 119

Italy Biologics Market 121

Italy Biologics Historic Market, 2013-2017 121

Italy Biologics Forecast Market, 2017-2021 122

Italy Biologics Market, 2017, By Segment 123

Spain Biologics Market Overview 124

Country Information 124

General Information 124

Government Initiatives 124

Regulations 124

Regulatory Bodies 124

Associations 124

Competitive Landscape 124

Spain Biologics Market 125

Spain Biologics Historic Market, 2013-2017 125

Spain Biologics Forecast Market, 2017-2021 126

Spain Biologics Market, 2017, By Segment 127

Eastern Europe Biologics Market 128

Eastern Europe Biologics Market Overview 128

Region Information 128

General Information 128

Government Initiatives 128

Regulations 128

Regulatory Bodies 128

Investments 128

Associations 128

Competitive Landscape 128

Eastern Europe Biologics Market 129

Eastern Europe Biologics Historic Market, 2013-2017 129

Eastern Europe Biologics Forecast Market, 2017-2021 130

Eastern Europe Biologics Market, 2017, By Segment 131

Russia Biologics Market Overview 132

Country Information 132

General Information 132

Government Initiatives 132

Regulations 132

Regulatory Bodies 132

Investments 132

Associations 132

Competitive Landscape 132

Russia Biologics Market 132

Russia Biologics Historic Market, 2013-2017 133

Russia Biologics Forecast Market, 2017-2021 134

Russia Biologics Market, 2017, By Segment 135

North America Biologics Market 136

North America Biologics Market Overview 136

Region Information 136

General Information 136

Regulations 136

Regulatory Bodies 136

Investments 137

Competitive Landscape 137

North America Biologics Market 137

North America Biologics Historic Market, 2013-2017 137

North America Biologics Forecast Market, 2017-2021 138

North America Biologics Market, 2017, By Segment 140

North America Biologics Market: Country Analysis 141

USA Biologics Market Overview 141

Country Information 141

General Information 141

Regulations 141

Regulatory Bodies 141

Investments 141

Competitive Landscape 141

USA Biologics Market 141

USA Biologics Historic Market, 2013-2017 142

USA Biologics Forecast Market, 2017-2021 144

USA Biologics Market, 2017, By Segment 145

South America Biologics Market 146

South America Biologics Market Overview 146

Region Information 146

General Information 146

Government Initiatives 146

Regulations 146

Regulatory Bodies 146

Associations 146

Competitive Landscape 146

South America Biologics Market 147

South America Biologics Historic Market, 2013-2017 147

South America Biologics Forecast Market, 2017-2021 148

South America Biologics Market, 2017, By Segment 149

South America Biologics Market: Country Analysis 151

Brazil Biologics Market Overview 151

Country Information 151

General Information 151

Government Initiatives 151

Regulations 151

Regulatory Bodies 151

Associations 151

Competitive Landscape 151

Brazil Biologics Market 152

Brazil Biologics Historic Market, 2013-2017 152

Brazil Biologics Forecast Market, 2017-2021 153

Brazil Biologics Market, 2017, By Segment 154

Middle East Biologics Market 155

Middle East Biologics Market Overview 155

Region Information 155

General Information 155

Regulations 155

Regulatory Bodies 155

Investments 155

Competitive Landscape 155

Middle East Biologics Market 156

Middle East Biologics Historic Market, 2013-2017 156

Middle East Biologics Forecast Market, 2017-2021 157

Middle East Biologics Market, 2017, By Segment 159

Africa Biologics Market 160

Africa Biologics Market Overview 160

Region Information 160

General Information 160

Regulations 160

Regulatory Bodies 160

Investments 161

Associations 161

Competitive Landscape 161

Africa Biologics Market 162

Africa Biologics Historic Market, 2013-2017 162

Africa Biologics Forecast Market, 2017-2021 163

Africa Biologics Market, 2017, By Segment 164

Biologics Market Competitive Landscape 166

Company Profiles 168

Johnson & Johnson (J&J) 168

F.Hoffmann-La Roche 168

Bristol-Myers Squibb 169

GlaxoSmithKline 169

AbbVie 170

Amgen 171

Sanofi 171

Eli Lilly and Company 172

Merck & Co. 173

Pfizer Inc. 173

Biologics Market Key Mergers And Acquisitions 176

Appendix 178

Market Data Sources 178

Primary Research - Interview Transcripts 178

Definitions 198

Research Methodology 198

Abbreviations 199

Currencies 199

Research Inquiries 199

The Business Research Company 199

Back to Top